Hepatitis E Virus Antibodies in Patients with Chronic Liver Disease
Muslim Atiq, Norah J. Shire, Anna Barrett and 3 more
Emerging Infectious Diseases · 2009
doi:10.3201/eid1503.080740 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
In the United States, the seroprevalence rate for hepatitis E virus (HEV) is approximately 20%. This study examined HEV seroprevalence in persons with and without chronic liver disease. Our data indicate that HEV seropositivity is high in patients with chronic liver disease and that HEV seroprevalence increases significantly with age.
Abstract licence: CC BY
References15
15 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.